Partial changes in apoptotic pathways in hippocampus and hypothalamus of Cc2d1a heterozygous

Metab Brain Dis. 2023 Feb;38(2):531-541. doi: 10.1007/s11011-022-01125-y. Epub 2022 Dec 1.

Abstract

Alterations in the apoptosis pathway have been linked to changes in serotonin levels seen in autistic patients. Cc2d1a is a repressor of the HTR1A gene involved in the serotonin pathway. The hippocampus and hypothalamus of Cc2d1a ± mice were analyzed for the expression of apoptosis markers (caspase 3, 8 and 9). Gender differences were observed in the expression levels of the three caspases consistent with some altered activity in the open-field assay. The number of apoptotic cells was significantly increased. We concluded that apoptotic pathways are only partially affected in the pathogenesis of the Cc2d1a heterozygous mouse model. A) Apoptosis is suppressed because the cell does not receive a death signal, or the receptor cannot activate the caspase 8 pathway despite the death signal. B) Since Caspase 8 and Caspase 3 expression is downregulated in our mouse model, the mechanism of apoptosis is not activated.

Keywords: Apoptosis; Autism; Cc2d1a; Hippocampus; Hypothalamus; Mouse.

MeSH terms

  • Animals
  • Apoptosis
  • Caspase 3 / metabolism
  • Caspase 8 / genetics
  • Caspase 8 / metabolism
  • Disease Models, Animal
  • Hippocampus / metabolism
  • Hypothalamus / metabolism
  • Mice
  • Serotonin* / metabolism
  • Signal Transduction* / physiology

Substances

  • Caspase 3
  • Caspase 8
  • Serotonin
  • Freud-1 protein, mouse